Silversmith Partners I GP LLC Buys Shares of 14,324,197 LifeStance Health Group, Inc. $LFST

Silversmith Partners I GP LLC acquired a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST) in the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 14,324,197 shares of the company’s stock, valued at approximately $100,842,000. LifeStance Health Group makes up approximately 100.0% of Silversmith Partners I GP LLC’s holdings, making the stock its largest holding.

Other large investors have also made changes to their positions in the company. Larson Financial Group LLC increased its position in shares of LifeStance Health Group by 19,952.6% in the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock valued at $27,000 after buying an additional 3,791 shares in the last quarter. Bayesian Capital Management LP bought a new stake in shares of LifeStance Health Group in the 2nd quarter valued at $52,000. Krane Funds Advisors LLC bought a new stake in shares of LifeStance Health Group in the 4th quarter valued at $71,000. Cibc World Markets Corp bought a new stake in shares of LifeStance Health Group in the 4th quarter valued at $77,000. Finally, CIBC Bancorp USA Inc. bought a new stake in shares of LifeStance Health Group in the 3rd quarter valued at $78,000. Institutional investors own 85.50% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on the stock. BTIG Research upped their price objective on shares of LifeStance Health Group from $11.00 to $12.00 and gave the company a “buy” rating in a research report on Friday, May 8th. KeyCorp upped their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the company an “overweight” rating in a research report on Thursday, February 26th. UBS Group upped their price objective on shares of LifeStance Health Group from $10.00 to $12.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Zacks Research upgraded shares of LifeStance Health Group from a “hold” rating to a “strong-buy” rating in a research report on Monday, April 27th. Finally, Jefferies Financial Group upgraded shares of LifeStance Health Group to a “strong-buy” rating in a research report on Thursday, March 12th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have given a Hold rating to the company. According to MarketBeat, LifeStance Health Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $9.75.

LifeStance Health Group Stock Down 1.3%

Shares of LFST opened at $8.50 on Friday. LifeStance Health Group, Inc. has a 12 month low of $3.74 and a 12 month high of $8.89. The firm’s 50 day moving average is $7.35 and its 200-day moving average is $7.06. The stock has a market capitalization of $3.30 billion, a PE ratio of 141.67 and a beta of 1.19. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.18.

LifeStance Health Group (NASDAQ:LFST) last announced its earnings results on Wednesday, May 6th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.01 by $0.03. LifeStance Health Group had a net margin of 1.55% and a return on equity of 1.56%. The company had revenue of $403.48 million for the quarter, compared to analysts’ expectations of $387.46 million. The firm’s quarterly revenue was up 21.2% compared to the same quarter last year. Equities research analysts forecast that LifeStance Health Group, Inc. will post 0.12 EPS for the current year.

LifeStance Health Group declared that its Board of Directors has approved a share repurchase program on Wednesday, February 25th that allows the company to buyback $100.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 3.6% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, Director Darren M. Black sold 5,899,661 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $8.02, for a total value of $47,315,281.22. Following the sale, the director owned 23,310,115 shares in the company, valued at $186,947,122.30. This trade represents a 20.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Eric Shuey sold 243,362 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $8.02, for a total transaction of $1,951,763.24. Following the completion of the sale, the director owned 867,562 shares in the company, valued at $6,957,847.24. This represents a 21.91% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 6,868,057 shares of company stock worth $55,048,226 over the last quarter. Corporate insiders own 3.20% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.